(FILES) An undated handout picture released by the University of Oxford on November 23, 2020 shows a vial of the University’s COVID-19 candidate vaccine, known as AZD1222, co-invented by the University of Oxford and Vaccitech in partnership with pharmaceutical giant AstraZeneca. – Britain on December 30, 2020 became the first country in the world to approve the coronavirus vaccine developed by drug firm AstraZeneca and Oxford University, with a mass rollout planned from January 4, 2021. (Photo by John Cairns / University of Oxford / AFP) /
The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).
The regulator, charged with overseeing vaccines’ authorisation in the EU before they can be marketed, approved the Pfizer-BioNTech vaccine on December 21. It is expected to rule on Moderna’s vaccine on January 6.
“No formal marketing authorisation has yet been submitted to EMA, therefore EMA’s committee for human medicines has not yet set a timetable” for approving the AstraZeneca-Oxford jab, the Amsterdam-based agency told AFP.
The regulator’s deputy executive director Noel Walthion told Belgian newspaper Het Nieuwsblad on Tuesday that a possible approval in January is “unlikely,” a statement confirmed by the agency late Tuesday.
The AstraZeneca-Oxford vaccine is currently undergoing a “rolling review” which allows the EMA to examine safety and efficacy data as they are released, even before a formal application for authorisation is filed by the manufacturer.
This procedure speeds up the evaluation of a marketing authorisation application once it is made, the EMA said.
Britain on Wednesday became the first country in the world to approve the vaccine, which is cheaper to produce and easier to store and transport than the Pfizer-BioNTech jab.
For EU countries, it is up to the European Commission in Brussels to issue the final green light after EMA approval.
Inoculations with the Pfizer-BioNTech vaccine began in the 27-member bloc over the weekend.
88838 679302This really is a right blog for would like to locate out about this topic. You realize a whole lot its almost challenging to argue along (not that I personally would wantHaHa). You in fact put the latest spin with a topic thats been discussed for a long time. Amazing stuff, just great! 541220
416863 112389It is actually a cool and useful piece of info. Im glad which you shared this beneficial details with us. Please keep us informed like this. Thanks for sharing. 184582
244591 150128Hmm is anyone else experiencing difficulties with the images on this weblog loading? Im trying to discover out if its a dilemma on my end or if its the weblog. Any responses would be greatly appreciated. 190206
662270 558078Id should consult you here. Which is not some thing It is my job to do! I spend time reading an post that could get men and women to feel. Also, a lot of thanks for permitting me to comment! 643626
115177 733874Hiya! Wonderful weblog! I happen to be a day-to-day visitor to your web site (somewhat far more like addict ) of this site. Just wanted to say I appreciate your blogs and am seeking forward for more! 628387
588843 237043Having been basically searching at helpful weblog articles with regard towards the project research when My partner and i happened to stumble on yours. Thanks for this practical data! 862484
971416 510146You ought to experience a contest personally of the finest blogs on-line. Im going to suggest this page! 381788
587474 804646Hello there! Do you know if they make any plugins to protect against hackers? Im kinda paranoid about losing everything Ive worked hard on. Any suggestions? 443762
431094 913640Deference to op , some superb selective info . 72699